ORANGE COUNTY, Calif., June 2 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, announces upcoming investor events. Please mark your calendars accordingly.
-- July 20 - 24, 2009, Chicago, Illinois - The American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Exposition. o AACC will host its annual IVD Industry Analyst Briefing on Monday afternoon, July 20, 2009, from 2:30 p.m. to 6:00 p.m. (ET) at the Hyatt Regency Chicago Hotel. RSVP to: Freddy Tellez at firstname.lastname@example.org. Questions: Please contact Jerry Goldsmith at email@example.com or 202-337-4278(ofc) or 202-436-5087(cell) -- Beckman Coulter will host an investor event Tuesday, July 21, 2009, from 7:30 a.m. to 9:00 a.m.. Register at: http://www.acteva.com/booking.cfm?bevaid=184612. For additional information, contact Beckman Coulter's Investor Relations Department at (714) 773-7620. -- AACC industry exhibits open on Tuesday, July 21 through Thursday, July 23, 2009, at the McCormick Place Convention Center, Chicago, Illinois. -- For general meeting information, go to www.aacc.org.
Please refer to the company's website at www.beckmancoulter.com for updates on other company events. To access this information from our site, select "go to IR" under Investor Relations and look for "What's Ahead".
Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies (including reagent test kits), service and operating-type lease payments, represent about 78% of the company's 2008 revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.
Contact: Cynthia Skoglund (714) 773-7620 Manager, Investor Relations
Copyright©2009 PR Newswire.
All rights reserved